Systemic sclerosis with lung involvement is a serious complication of an autoimmune disease that affects not only the skin but also the lungs, creating challenges that can significantly impact breathing and overall health.

Understanding Systemic Sclerosis and Lung Disease

Systemic sclerosis, also known as scleroderma, is a rare connective tissue disorder in which the body’s immune system mistakenly attacks its own tissues. When this happens, it leads to excessive inflammation and increased production of collagen, a protein that provides structure to tissues. This overproduction causes scarring or fibrosis in various organs throughout the body^[4]. The condition is particularly concerning when it affects the lungs, resulting in what doctors call interstitial lung disease, or ILD, which represents one of the most serious complications of systemic sclerosis.

When systemic sclerosis affects the lungs, it causes damage to the delicate tissue between the air sacs, leading to scarring that makes breathing progressively more difficult. This lung involvement has become one of the leading causes of death in people with systemic sclerosis, accounting for approximately 20 to 40 percent of mortality in this patient population^[8]. The risk of developing lung disease is greatest early in the course of systemic sclerosis, which makes timely detection crucial for monitoring progression and making treatment decisions^[8].

The manifestations of systemic sclerosis can vary widely from person to person, making it a highly heterogeneous condition. Some individuals experience limited skin involvement, while others develop more widespread changes affecting larger areas of the body. This variability extends to internal organ involvement as well, with some people developing severe lung complications while others may have minimal respiratory symptoms^[5].

How Common Is Lung Involvement in Systemic Sclerosis

Lung involvement in systemic sclerosis is remarkably common, occurring in approximately 35 to 52 percent of all patients with this condition^[8]. According to data from national observational registries and international patient cohorts, roughly 65 percent of people with systemic sclerosis have or will develop interstitial lung disease at some point during their disease course^[10]. These numbers underscore the importance of lung monitoring as a routine part of systemic sclerosis care.

In one hospital-based study examining patients with systemic sclerosis, researchers found that among 53 individuals who met the diagnostic criteria for the disease, 21 had the limited form and others had more extensive disease manifestations^[2]. The prevalence of organ involvement can be difficult to estimate precisely because lung damage often occurs early in the disease process, sometimes before patients notice any breathing difficulties or other respiratory symptoms.

Systemic sclerosis itself is considered a rare disease, more commonly affecting women than men. It typically begins between ages 25 and 55, although cases have been reported in children and older individuals as well^[4]. The condition shows some geographic variation in prevalence, but it affects people across all ethnic backgrounds and regions worldwide.

What Causes Systemic Sclerosis With Lung Involvement

The exact cause of systemic sclerosis remains unknown, representing one of the major challenges in understanding and treating this disease. However, researchers have identified that it is an autoimmune condition, meaning the immune system becomes confused and begins attacking the body’s own connective tissues, including blood vessels, cartilage, and tendons^[4]. This immune system malfunction triggers a cascade of problems that eventually lead to organ damage.

The disease process appears to begin with inflammation in the blood vessels. When the immune system damages these vessels, it causes additional inflammation, which in turn leads to more tissue damage and the formation of autoantibodies—immune proteins that mistakenly target the body’s own structures. This combination of inflammation, damaged blood vessels, and autoantibodies results in the characteristic scarring seen in the skin and internal organs^[14].

When the lungs are affected, the inflammation and scarring specifically damage the interstitium, which is the delicate tissue between the air sacs in the lungs. As this tissue becomes scarred and thickened, it becomes increasingly difficult for oxygen to pass from the lungs into the bloodstream. The exact mechanisms that determine why some people with systemic sclerosis develop severe lung involvement while others do not remain an active area of research.

Certain genetic factors appear to play a role in disease susceptibility. The risk of developing systemic sclerosis is higher if a family member also has the condition, suggesting some hereditary component^[14]. Environmental factors may also contribute to disease development. People exposed to silica dust, certain solvents and chemicals, and specific medications have shown an increased risk of developing systemic sclerosis. In some cases, having an underlying cancer may trigger the disease process as well^[14].

Risk Factors for Developing Lung Disease

While anyone with systemic sclerosis can potentially develop lung involvement, certain factors increase the likelihood of this complication. Understanding these risk factors helps doctors identify which patients need especially close monitoring and potentially earlier intervention.

Male sex represents one significant risk factor, as men with systemic sclerosis appear more likely to develop interstitial lung disease compared to women^[8]. African-American race is associated with both an increased risk of developing lung involvement and potentially more rapid progression of lung disease^[8]. These demographic patterns help guide screening recommendations, though all patients with systemic sclerosis require lung monitoring regardless of these factors.

The subtype of systemic sclerosis also influences lung disease risk. People with diffuse cutaneous systemic sclerosis, which involves skin thickening on larger areas of the body including the trunk and areas above the elbows and knees, face higher risks of lung complications compared to those with limited skin involvement^[8]. The presence of specific autoantibodies in the blood provides additional clues about lung disease risk. Individuals with anti-Scl-70 antibodies (also called anti-topoisomerase I antibodies) have a particularly high likelihood of developing interstitial lung disease^[8].

Cardiac involvement, meaning the disease has affected the heart as well, increases the risk of pulmonary complications^[8]. Smoking represents a modifiable risk factor that can worsen lung disease and cause narrowing of blood vessels throughout the body. Stopping smoking is essential for anyone with systemic sclerosis, as continued tobacco use can accelerate disease progression^[4].

Recognizing the Symptoms

The symptoms of lung involvement in systemic sclerosis can develop gradually, sometimes so slowly that patients may not immediately recognize them as signs of a problem. This gradual onset makes regular medical monitoring especially important, as objective tests may detect lung changes before symptoms become obvious.

Shortness of breath, particularly during physical activity, represents the most common symptom of lung involvement. People may notice they become winded more easily when climbing stairs, walking uphill, or performing activities that previously caused no difficulty^[4]. This breathlessness often starts subtly and progressively worsens over time. Some individuals may attribute these changes to aging or being out of shape, potentially delaying medical evaluation.

A persistent cough is another hallmark symptom of systemic sclerosis-related lung disease^[4]. This cough is typically dry, meaning it does not produce mucus or phlegm. It may be more noticeable at certain times of day or may worsen gradually over weeks and months. Fatigue and decreased exercise tolerance often accompany the breathing difficulties, as the body struggles to obtain adequate oxygen during physical exertion.

Beyond lung-specific symptoms, people with systemic sclerosis often experience manifestations affecting other body systems. Most individuals develop Raynaud’s phenomenon, which causes the fingers to change color (turning white, blue, and then red) in response to cold temperatures or emotional stress^[14]. Skin thickening and tightening is characteristic of the disease and may make it difficult to fully open the mouth or make a fist. Difficulty swallowing is common because the condition can affect the esophagus and digestive tract^[4].

Some patients with systemic sclerosis develop pulmonary hypertension, which means increased blood pressure in the circulation to the lungs. This complication can cause additional symptoms including a racing or fast heartbeat, chest pain, swelling of the legs, and profound tiredness^[4]. When pulmonary hypertension coexists with interstitial lung disease, it further complicates both diagnosis and treatment.

Prevention and Early Detection Strategies

Since the underlying cause of systemic sclerosis remains unknown, no proven strategies exist to prevent the disease itself from developing. However, for people already diagnosed with systemic sclerosis, important steps can help prevent or slow the progression of lung involvement.

Smoking cessation ranks among the most critical preventive measures. Tobacco smoke damages lung tissue and causes blood vessels to constrict, both of which can worsen systemic sclerosis-related lung disease^[4]. People with systemic sclerosis who smoke should receive comprehensive support to quit, including counseling, nicotine replacement therapy, or medications if appropriate. Avoiding secondhand smoke exposure is also important.

Expert consensus strongly recommends that all patients with systemic sclerosis undergo screening for lung involvement, regardless of whether they have respiratory symptoms^[8]. This screening should include several components: chest auscultation (listening to the lungs with a stethoscope), spirometry (breathing tests that measure lung function), measurement of diffusing capacity (which assesses how well oxygen moves from the lungs into the blood), and high-resolution computed tomography (HRCT) scans of the chest^[8].

Autoantibody testing provides valuable information about lung disease risk and can guide monitoring strategies^[8]. Regular follow-up appointments allow doctors to track any changes in lung function over time. The frequency of monitoring depends on individual risk factors and baseline findings, but typically includes pulmonary function tests every three to six months for those with known lung involvement or high risk factors^[10].

Protecting the lungs from infections represents another important preventive strategy. People with systemic sclerosis should receive recommended vaccinations, including annual influenza vaccines and pneumococcal vaccines to prevent pneumonia. Prompt treatment of respiratory infections can help prevent additional lung damage.

How Lung Involvement Changes Normal Body Function

Understanding what happens in the lungs during systemic sclerosis helps explain why symptoms develop and why treatment is necessary. The lungs normally function as delicate structures where oxygen from inhaled air passes through thin membranes into the bloodstream, while carbon dioxide moves from the blood into the lungs to be exhaled. This gas exchange occurs in millions of tiny air sacs called alveoli, which are surrounded by an intricate network of blood vessels.

In systemic sclerosis with lung involvement, the immune system’s attack on lung tissue triggers inflammation in the interstitium—the thin tissue between and around the alveoli. This inflammation leads to the activation of cells called fibroblasts, which normally help repair damaged tissue by producing collagen. However, in systemic sclerosis, these fibroblasts become overactive and produce excessive amounts of collagen^[3].

As excess collagen accumulates, it causes the delicate lung tissue to become thick and stiff, much like scar tissue. This scarring process, called fibrosis, makes the lungs less elastic and reduces their ability to expand and contract efficiently during breathing. The thickened tissue also increases the distance that oxygen must travel to reach the blood vessels, making gas exchange less efficient^[3].

The blood vessels in the lungs may also be directly affected by the disease process. Damage to these vessels can lead to pulmonary hypertension, where the pressure in the lung circulation becomes abnormally elevated. This increased pressure forces the right side of the heart to work harder to pump blood through the lungs. Over time, this extra workload can weaken the heart^[9].

As lung function declines, the body receives less oxygen with each breath. This oxygen deficiency, called hypoxia, explains many of the symptoms people experience. The body tries to compensate by making the heart beat faster and by increasing the breathing rate, which is why people with lung involvement often feel short of breath and fatigued. During physical activity, when the body’s oxygen demands increase, these symptoms become more pronounced.

The combination of fibrosis and potential vascular changes creates a pattern of restrictive lung disease, where the lungs cannot expand fully. This differs from conditions like asthma, where the main problem is narrowed airways. In restrictive lung disease, the fundamental issue is reduced lung capacity and impaired gas exchange due to structural changes in the lung tissue itself.